Fintel reports that on January 7, 2025, Evercore ISI Group downgraded their outlook for DENTSPLY SIRONA (NasdaqGS:XRAY) from ...

DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 43rd Annual J.P. Morgan Healthcare Conference. Management is scheduled ...

Everence Capital Management Inc. acquired a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the 4th quarter, ...

In a report released today, Allen Lutz from Bank of America Securities maintained a Hold rating on DENTSPLY SIRONA (XRAY – Research Report).

Levi & Korsinsky, LLP notifies investors in Dentsply Sirona Inc. ("Dentsply" or the "Company") of a class action securities ...

DENTSPLY SIRONA Inc (XRAY) stock saw a modest uptick, ending the day at $18.85 which represents a slight increase of $0.24 or 1.29% from the prior close of $18.61. The stock opened at $18.51 and ...

DENTSPLY SIRONA (XRAY – Research Report) received a Hold rating and price target from Evercore ISI analyst Elizabeth Anderson CFA today. The ...

Robbins LLP reminds investors that a class action was filed on behalf of persons and entities that purchased Dentsply Sirona Inc. common stock between December 1, 2022 and November 6, 2024. Dentsply ...

Mizuho has recently initiated DENTSPLY SIRONA Inc (XRAY) stock to Neutral rating, as announced on December 4, 2024, according to Finviz. Earlier, on November 7, 2024, Leerink Partners had reduced the ...

The complaints allege that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) DENTSPLY targeted low-income people who did not have ...

NDAQ:XRAY) ROSEN, A LEADING LAW FIRM, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRAY ...

The complaints allege that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to ...